Theme · live manifest · live theme JSON
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med
6 tickers · $17.54B total market cap
Group: MedTech Long
This basket captures companies at the frontier of bioanalytical tools, regenerative medicine, next-gen diagnostics, and precision therapies. These firms are positioned to benefit from the Trump 2.0 administration's pro-innovation FDA posture, growing interest in non-traditional and precision modalities, and a recovery in biotech funding and clinical demand. Several names (e.g., QTRX, MASS) are trading well below strategic asset value despite compelling IP, partnerships, or earnings inflection points.
MedTech Long '25: Adv Bio Therapeutics & Regenerative Med tracks 6 publicly listed stocks in this theme: 3696.HK, ARQT, HALO, OBIO, VCEL, WVE. See the constituent table for details.
Thesis update: 2025-04-14
Constituents
Build 20260520T081747
| Company | Previous Quarter Report Date | Next Expected Report Date | Last Quarter Earnings Move % | Earnings Move % | Intra-Quarter Move % | Since Last Report % | Market cap | Weight |
|---|---|---|---|---|---|---|---|---|
Halozyme Therapeutics, Inc.HALO | 05/11/2026 (AMC) | 05/11/2026 (AMC) | -10.49% | 10.62% | -7.82% | -3.10% | $8.15B | 16.6667 |
InSilico Medicine Cayman TopCo3696.HK | — | — | — | — | — | — | $3.77B | 16.6667 |
Arcutis Biotherapeutics, Inc.ARQT | 05/06/2026 (AMC) | 05/06/2026 (AMC) | -0.15% | -11.78% | -10.38% | -5.61% | $2.44B | 16.6667 |
Vericel CorporationVCEL | 05/07/2026 (BMO) | 05/07/2026 (BMO) | -3.80% | -9.03% | 3.08% | 3.08% | $1.76B | 16.6667 |
Wave Life Sciences Ltd.WVE | 04/28/2026 (BMO) | 04/28/2026 (BMO) | -4.20% | 1.59% | -50.18% | -12.91% | $1.18B | 16.6667 |
Orchestra BioMed Holdings, Inc.OBIO | 05/12/2026 (AMC) | 05/12/2026 (AMC) | -4.11% | 3.84% | -3.33% | -1.48% | $239.5M | 16.6667 |
| Average | -4.55% | -0.95% | -13.73% | -4.00% | $2.92B | 16.6667 | ||
| Median | -4.11% | 1.59% | -7.82% | -3.10% | $2.10B | 16.6667 | ||
| Std Dev | 3.33% | 8.32% | 18.79% | 5.28% | $2.58B | 0.0% | ||
| Min | -10.49% | -11.78% | -50.18% | -12.91% | $239.5M | 16.6667 | ||
| Max | -0.15% | 10.62% | 3.08% | 3.08% | $8.15B | 16.6667 | ||
| % Positive Tickers | 0.00% | 60.00% | 20.00% | 20.00% |
* Provisional value: before LstRpt% reaches its 2-day post-report lock window (BMO/AMC adjusted), EarningsPerf is calculated from current vs pre-report and then locks to final LstRpt%.